课题基金 / 基金详情

Brain magnetic stimulation to reduce levodopa-induced dyskinesias in Parkinson's disease

Brain magnetic stimulation to reduce levodopa-induced dyskinesias in Parkinson's disease
脑磁刺激可减少帕金森病中左旋多巴引起的运动障碍
批准号：
488794
负责人：
Di Paolo-Chenevert Thrèse
金额：
$20.06万
依托单位：
Universit Laval
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2023
资助国家：
加拿大
项目状态：
未结题
起止时间：
2023-09-01 至 2025-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=488794&lang=en
关键词：
Amantadine Brain Magnetic Stimulation Dopamine Dyskinesias Glutamate Receptors Levodopa Monkey Motor Behaviour Measures Mptp Parkinson'S Disease

项目摘要

项目成果

Di Paolo-Chenevert Thrèse的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The chronic exposure of people with Parkinson's disease (PD) to levodopa, the gold standard medication, mostly leads to the development of abnormal involuntary movements called dyskinesias that reduce the quality of life and are difficult to treat. Dyskin
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms of therapeutic efficacy of deep brain stimulation in Parkinson's disease
Gonadal drugs for brain neuroprotection and neuromodulation
Bioavailable plasmalogen precursors in models of Parkinson's disease.
海外基金